NCT03230487 This Study Tests How Healthy Men Tolerate Different Doses of BI1015550. The Study Also Tests How BI 1015550 is Taken up by the Body Status COMPLETED Phase PHASE1
NCT03230097 This Study Tests Whether BI 409306 Prevents Patients With a Specific Type of Mental Illness (Attenuated Psychosis Syndrome) From Becoming Worse. This Study Looks at How Well Patients Tolerate the Medicine and How Effective it is Over 1 Year Status TERMINATED Phase PHASE2
NCT03222765 Prevention of Microvascular Complications in Prediabetes e-PREDICE Study Status UNKNOWN Phase NA
NCT03215069 Empagliflozin and the Preservation of Beta-cell Function in Women with Recent Gestational Diabetes Status COMPLETED Phase PHASE3
NCT03210272 This Study in Healthy Men Tests How Different Doses of BI 1358894 Are Taken up in the Body and How Well They Are Tolerated. The Study Also Looks at How Food Influences the Amount of BI 1358894 in the Blood Status COMPLETED Phase PHASE1
NCT03210259 The VOLTAIRE-X Trial Looks at the Effect of Switching Between Humira® and BI 695501 in Patients With Plaque Psoriasis Status COMPLETED Phase PHASE3
NCT03207191 Trial to Find and Investigate a Safe Dose of F16IL2 and BI 836858 in Patients With AML Relapse After Allogeneic Hematopoietic Stem Cell Transplantation Status COMPLETED Phase PHASE1
NCT03206632 This Study is Done in Healthy Chinese and Japanese Volunteers; it Looks at How BI 690517 is Taken up in the Body and How Well it is Tolerated Status COMPLETED Phase PHASE1
NCT03205137 Comparison of the Medication Adherence of Patients Treated With Telmisartan/Hydrochlorothiazide or Telmisartan/Amlodipine Fixed Dose Combination (FDC) Versus Double-pill Combination Therapy in Real-world Japanese Therapeutic Practice Status WITHDRAWN Phase N/A
NCT03195088 Evaluation of Safety and Tolerability of Single Rising Doses of BI 473494 in Healthy Subjects Status TERMINATED Phase PHASE1
NCT03193307 This Study Tests in Healthy Korean Women Which Effects BI 409306 and a Birth-control Pill Have on Each Other Status COMPLETED Phase PHASE1
NCT03187197 Patients' Assessment of Satisfaction for Stroke Prevention in Atrial Fibrillation Status COMPLETED Phase N/A
NCT03175211 Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 456906 in Healthy Male Volunteers Status COMPLETED Phase PHASE1
NCT03166735 Different Doses of BI 1467335 Compared to Placebo in Patients With Clinical Evidence of NASH Status COMPLETED Phase PHASE2
NCT03166631 A Trial to Find the Safe Dose for BI 891065 Alone and in Combination With BI 754091 in Patients With Incurable Tumours or Tumours That Have Spread Status TERMINATED Phase PHASE1
NCT03165240 This International Study Tests BI 690517 in Patients With Diabetic Kidney Disease. The Study Tests How 3 Different Doses of BI 690517 Are Taken up in the Body and How Well They Are Tolerated Status COMPLETED Phase PHASE1
NCT03165227 This Study Tests a New Medicine Called BI 685509 in Patients That Have Kidney Problems Because of Diabetes. The Study Tests How BI 685509 is Taken up in the Body and How Well it is Tolerated (Multiple Rising Doses) Status COMPLETED Phase PHASE1
NCT03165045 Changes in Health and Functional Status in Patients With Chronic Obstructive Pulmonary Disease During Therapy With Spiolto® Respimat® (AERIAL®) Status COMPLETED Phase N/A